Evidence map›Paper›PMID 36463143›Full record

ArticleBMC women's health2022

Evaluation of the CNC

Alessandra Petruzzi, Anna Maria Mancuso, Sara Alfieri, Antonella Esposito, Gabriele Infante, Rosalba Miceli, Stefano Ospitali, Carla Ida Ripamonti, Claudia Borreani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC women's health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Alessandra PetruzziSalute Donna Onlus Association, Milan, Italy.
Anna Maria MancusoSalute Donna Onlus Association, Milan, Italy.
Sara AlfieriClinical Psychology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133, Milan, Italy. sara.alfieri@istitutotumori.mi.it.ORCID 0000-0002-2183-240X
Antonella EspositoSalute Donna Onlus Association, Milan, Italy.
Gabriele InfanteLaboratory of Medical Statistics, Biometry and Epidemiology "G. A. Maccacaro", Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Rosalba MiceliS.S. Biostatistics for Clinical Research, Department Epidemiology and Data Science Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Stefano OspitaliAdvihair Srl, Zola Predosa, Bologna, Italy.
Carla Ida RipamontiSupportive Care in Cancer Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Claudia BorreaniClinical Psychology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Giacomo Venezian 1, 20133, Milan, Italy.
Fondazione IRCCS Istituto Nazionale dei Tumori · ITEuropa Donna · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChemotherapy-induced alopecia (CIA), although generally reversible, is felt as extremely distressing by patients with breast cancer. A certified medical device (Capelli Naturali a Contatto

aimsThe present study aimed to evaluate the impact of the CNC

methodA pilot study was carried out on 21 patients affected by CIA due to recurrent breast cancer. A mixed quantitative/qualitative method was used, including administering a questionnaire and a focus group.

resultsBased on the Body Image Scale, body image perception improved after 3 and 6 months using the device in the 20 patients who answered the questionnaire. No significant change over time emerged for the six dimensions investigated by the Italian version of the Psychological Well-Being Scale. The thematic analysis of the focus groups showed six themes: definition of the prosthetic device, acceptance of the proposal, experience with the conventional wig, strengths, weaknesses, economic issues.

conclusionCompared to the previous experience of CIA and the standard wig, the use of the CNC

Indexed as

Antineoplastic AgentsBreast NeoplasmsAlopeciaBody ImageFemaleHumansPilot ProjectsAntineoplastic AgentsBody imageChemotherapy-induced alopeciaCNC® deviceMixed-methodQuality of lifeRecurrent breast cancerWellbeing

Identifiers

PMID36463143
PMCPMC9719124
OpenAlexW4311197425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.